Ronald Brown
Interventional Cardiology · Salt Lake City, UTNPI 1447242060
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $690 and has fallen 52.9% since, to $325 in 2023. That places this record below the midpoint for interventional cardiology clinicians in UT, where the typical reported total is $5,946.
Across 97 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$385
- E.r. Squibb & Sons, L.L.C.$185
- Boston Scientific$166
- Lilly USA, LLC$141
- Pfizer$128
- Johnson & Johnson$107
- plus $514 from 17 others
What the payments were for
- Food & beverage$1,620100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 18 | $385 |
| E.r. Squibb & Sons, L.L.C. | 12 | $185 |
| Boston Scientific | 12 | $166 |
| Lilly USA, LLC | 9 | $141 |
| Pfizer | 8 | $128 |
| Johnson & Johnson | 8 | $107 |
| Actelion Pharmaceuticals US, Inc. | 6 | $63 |
| Abbott | 2 | $59 |
| Bayer | 3 | $53 |
| Merck | 3 | $51 |
| Novo Nordisk | 2 | $38 |
| Novartis | 2 | $36 |
| Exact Sciences | 2 | $32 |
| Irhythm Technologies, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Boehringer Ingelheim | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $18 |
| GSK | 1 | $16 |
| Viiv Healthcare Company | 1 | $16 |
| Lucid Diagnostics Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Portola Pharmaceuticals, LLC | 1 | $13 |
How this compares
$1,626 in reported general payments places this provider in the 25th percentile of 45 interventional cardiology providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 97 | $107,021 |
| XareltoRivaroxaban | 14 | $22,001 |
| Repatha SureclickEvolocumab | 18 | $13,151 |
| EntrestoSacubitril/Valsartan | 11 | $7,571 |
| Repatha SyringeEvolocumab | 11 | $7,071 |
| Praluent PenAlirocumab | 12 | $6,088 |
| Metoprolol Succinate | 142 | $2,013 |
| Amiodarone Hcl | 82 | $1,484 |
| Rosuvastatin Calcium | 127 | $1,440 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 45 | $1,411 |
| Atorvastatin Calcium | 126 | $1,227 |
| Carvedilol | 138 | $1,105 |
| Potassium Chloride | 58 | $1,008 |
| Losartan Potassium | 72 | $945 |
| Flecainide Acetate | 16 | $810 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $128 | $107,02197 claims |
| Johnson & JohnsonXarelto | $107 | $22,00114 claims |
| NovartisEntresto | $36 | $7,57111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 45 interventional cardiology providers in Utah.
Other interventional cardiology in Salt Lake City
- Vamsee YagantiSalt Lake City$390K
- Anwar TandarSalt Lake City$131K
- Stavros DrakosSalt Lake City$79K
- Frederick WeltSalt Lake City$26K
- Scott HackingSalt Lake City$22K
- Eric LindleySalt Lake City$18K
- Lee LinstrothSalt Lake City$14K
- Theophilus OwanSalt Lake City$9K
- Diana MeloSalt Lake City$4K
- Tara JonesSalt Lake City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.